Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-004042

Chief Financial Officer sold 1,000 shares at $238.98 ($238,980)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-10 Sale : show line 1 in the form 10b5-1 −1,000 $238.98 $238,980 91,864 D
Open-market sales · 1,000 sh · avg $238.98 · $238,980
Loading xslF345X05/form4.xml…